The Role of PPAR-γ in Pancreatic Cancer
Author Information
Author(s): Guido Eibl
Primary Institution: Hirshberg Laboratories for Pancreatic Cancer Research, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles
Hypothesis
What is the role of PPAR-γ in pancreatic cancer development and progression?
Conclusion
PPAR-γ activation may lead to enhanced angiogenesis and tumor growth in pancreatic cancer.
Supporting Evidence
- PPAR-γ is overexpressed in various cancers, including pancreatic cancer.
- Activation of PPAR-γ can stimulate VEGF production, which promotes tumor angiogenesis.
- Thiazolidinedione ligands can reduce pancreatic cancer cell growth in vitro.
Takeaway
This study looks at how a protein called PPAR-γ might help or hurt pancreatic cancer. It finds that while it can stop cancer cells from growing, it might also help them grow by making new blood vessels.
Methodology
The review summarizes existing data on PPAR-γ in pancreatic cancer and discusses its interactions with COX-2.
Limitations
The review highlights the lack of clinical data on PPAR-γ in pancreatic cancer and the need for further studies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website